Device

Why Philips' Erik Hollander turned to reinvention

Why Philips' Erik Hollander turned to reinvention

By

He describes his current charge as "transforming a more creative occupation into a science."

What uncertainty? 72% of health marketers say 2017 budgets are up

What uncertainty? 72% of health marketers say 2017 budgets are up

By

This according to the 172 healthcare marketing executives who participated in the 2017 MM&M/Guidemark Health Healthcare Marketers Trend Report.

Five things for pharma marketers to know: Wednesday, January 25, 2017

Five things for pharma marketers to know: Wednesday, January 25, 2017

By

Novartis forecasts slower growth in 2017; Actelion reports trial failure for PAH drug; HHS nominee Tom Price denies conflict of interest claims

Five things for pharma marketers to know: Wednesday, December 21, 2016

Five things for pharma marketers to know: Wednesday, December 21, 2016

By

GSK's two-drug combo for HIV has positive Phase-III results; the FDA approves glucose system that doesn't use finger pricking; Rite Aid to sell stores

Philips takes the pharma Grand Prix at Cannes

Philips takes the pharma Grand Prix at Cannes

By

Ogilvy & Mather London developed the campaign, called Breathless Choir and set to Sting's "Every Breath You Take."

Five things for pharma marketers to know: Thursday, May 26, 2016

Five things for pharma marketers to know: Thursday, May 26, 2016

By

BIO report finds success rate in Phase-I is 10%; Dunsire departs Forum after failed trials; the FDA issues two warning letters

New mobile app seeks to address medication adherence

New mobile app seeks to address medication adherence

By

CeyHello, a newly launched social networking mobile app, tackles medication adherence by connecting patients, caregivers and family members.

Providers, devicemakers lag in IT defense

Providers, devicemakers lag in IT defense

While it's made great strides, the healthcare industry is still behind in some technology and information safeguards.

Digital still not top priority in healthcare: survey

Digital still not top priority in healthcare: survey

By

Part of the challenge for drugmakers, medical-device makers and healthcare providers is finding the right digital talent and advocating for cultural changes within their organizations.

Five things for pharma marketers to know: Wednesday, July 29

Five things for pharma marketers to know: Wednesday, July 29

By

Drug spending projected to grow at 6% clip through 2024, spurred in part by pricey new medications; FDA approves new obesity device; Sanofi diabetes combo drug is better at reducing blood glucose than Lantus.

Manufacturers pay $6.5 billion to healthcare providers in 2014

Manufacturers pay $6.5 billion to healthcare providers in 2014

By

The government released new data showing how much pharma and device companies spent for research and marketing purposes last year.

Five things for pharma marketers to know: Monday, May 4

Five things for pharma marketers to know: Monday, May 4

By

Drugmakers engage early with insurers; patients push for implant to be pulled from the market; about one-third of new drugs qualify for special approval pathways

Medtronic agrees to consent decree

The manufacturer's SynchroMed drug-infusion pump was associated with 14 deaths.

Editor's Desk: And the researchers go wild

Editor's Desk: And the researchers go wild

By

Apple's ResearchKit could accelerate the pace at which industry approaches start-ups building products in the patient-facing part of health tech

FDA approves Boston Scientific atrial fibrillation device

The approval follows three advisory panel reviews and a complete response letter.

Device maker pays feds $2.8M over physician false claims

Device maker pays feds $2.8M over physician false claims

By

Medtronic, as part of the settlement, will pay $602,000 to a whistleblower to settle charges it caused physicians to submit false claims to federal health programs.

J&J pulls morcellator from market

The company is calling the move a withdrawal, as opposed to a recall.

GE buys interest in DNA

The finance, electric and broadcasting company has taken a $1-billion interest in DNA technology.

Covidien buys firm armed with missile tech

Covidien is buying ingestible-camera company Given Imaging.

Report: J&J nearing hip settlement

The current number is reported to hover around $4 billion.

FDA exempts most mobile apps from scrutiny

FDA exempts most mobile apps from scrutiny

By

The agency issued final guidance on mobile apps, saying it will focus only on a subset that present the greatest risk to patients if they don't work correctly.

"Sensor you swallow" passes psych test

"Sensor you swallow" passes psych test

By

Proteus Digital Health's ingestible sensor shows utility as an adherence tool for those on psych meds, a study suggests.

Mayo device helps monitor heart patients from afar

By

Device maker Preventice says the peel-and-stick monitor has the potential to go beyond the critical care market and into the sports world.

J&J consolidates, rebrands Ethicon units

J&J consolidates, rebrands Ethicon units

By

Driven by consolidation in the healthcare industry, J&J is reuniting Ethicon, Inc. and Ethicon Endo-Surgery to present surgeons and health systems with a single face.

Abbott closes Q1 with sales boost

By

The company expects emerging markets to rise in importance and says it's scoping out possible device acquisitions.

Senate vote puts ACA's device tax in doubt

Senate vote puts ACA's device tax in doubt

By

In a big win for the device industry, Senators voted overwhelmingly on a symbolic— but politically potent—motion to scrap the 2.3% device excise tax.

WebMD digs deeper into the everyday

WebMD digs deeper into the everyday

By

A deal with QualcommLife aims to fuse WebMD content with a suite of disease state management tools.

Growth in devices, online video to drive media this year, buyers say

What changes in marketing or audience viewing habits might impact pharma's media investment this year? Media buyers weigh in on the hot channel trends.

DePuy coaches joint pain sufferers not to delay surgery

DePuy coaches joint pain sufferers not to delay surgery

By

A new campaign from J&J's DePuy Orthopedics, aimed at raising awareness of joint replacement, features Baby Boomers' letters to their younger selves.

Baxter to buy hemodialysis giant Gambro AB for $4 billion

Baxter to buy hemodialysis giant Gambro AB for $4 billion

By

After almost a year of negotiations, Baxter has reached a $4 billion deal for Swedish firm Gambro AB as it makes a play for the kidney dialysis market.

Opinion

How to Shatter the Glass Ceiling

How Pharma Can Benefit from the Transformation of Pharmacy

Newsletters

Live at MM&M Transforming Healthcare

Pharma faces its 'oh, shit' moment

In his keynote address at the MM&M Transforming Healthcare conference, Dr. Gautam Gulati says the industry is being outpaced by its innovation.

Merck, Takeda execs: Is AI the new bad app?

One executive referred to AI as a "black box" and as the "Tower of Babel."

Value-based care requires innovators to challenge the status quo

Execs stressed the importance of collaboration, consumer-mindedness.

Admetsys wins the 2017 MM&M Startup Showdown

The artificial pancreas can provide value to the health system.

Top 40 Healthcare Transformers

MM&M honors 40 upstarts and veteran innovation gurus.

Top 10 Innovation Catalysts

For the first time MM&M honors a group of 10 agency execs.